SEC Form 4 · accession 0001591868-17-000002
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Baker Flechtner
Officer — Chief Scientific Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.67 | Feb 28, 2017 | A | 100,000 | A | — | Feb 28, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F11. The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.